Healthy volunteers test new diabetes drug combo in Early-Stage trial
NCT ID NCT07158346
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 27 times
Summary
This early-stage study tested how two experimental drugs (L03RD1 and L03RD2) behave in the body when given together, compared to a combined version (CT-L03). 49 healthy adults took part. The goal was to measure drug levels and safety, not to treat diabetes directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
H plus Yangji Hostpital
Seoul, 08756, South Korea
Conditions
Explore the condition pages connected to this study.